ES2066020T3 - Concentrado de factor von willebrand pasteurizado y purificado y procedimiento para su preparacion. - Google Patents

Concentrado de factor von willebrand pasteurizado y purificado y procedimiento para su preparacion.

Info

Publication number
ES2066020T3
ES2066020T3 ES90102716T ES90102716T ES2066020T3 ES 2066020 T3 ES2066020 T3 ES 2066020T3 ES 90102716 T ES90102716 T ES 90102716T ES 90102716 T ES90102716 T ES 90102716T ES 2066020 T3 ES2066020 T3 ES 2066020T3
Authority
ES
Spain
Prior art keywords
concentrate
pasteurized
procedure
purified
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90102716T
Other languages
English (en)
Inventor
Norbert Prof Dr Heimburger
Gerhard Kumpe
Klaus Wellner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6374025&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2066020(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Behringwerke AG filed Critical Behringwerke AG
Application granted granted Critical
Publication of ES2066020T3 publication Critical patent/ES2066020T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)

Abstract

EL INVENTO DESCRIBE UN PROCEDIMIENTO PARA LA PRODUCCION PARA LA PRODUCCION DE UNOS CONCENTRADOS DE FACTRES LIBRES DE AÑUBLO QUE CONSISTE EN PASTERIZAR UNA SOLUCION DE UNOS COMPLEJOS DE ESTOS FACTORES CON FACTOR VIII; C Y TRATAR EL PRODUCTO PASTEURIZADO EN UN INTERCAMBIADOR DE ANIONES, PARA OBTENER UN CONCENTRADO CON FACTORES LIBRES DE AÑUBLO Y UN PRODUCTO RESIDUAL SEPARADO DEL CONCENTRADO.
ES90102716T 1989-02-14 1990-02-12 Concentrado de factor von willebrand pasteurizado y purificado y procedimiento para su preparacion. Expired - Lifetime ES2066020T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3904354A DE3904354A1 (de) 1989-02-14 1989-02-14 Pasteurisiertes, gereinigtes von willebrand-faktor-konzentrat und verfahren zu seiner herstellung

Publications (1)

Publication Number Publication Date
ES2066020T3 true ES2066020T3 (es) 1995-03-01

Family

ID=6374025

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90102716T Expired - Lifetime ES2066020T3 (es) 1989-02-14 1990-02-12 Concentrado de factor von willebrand pasteurizado y purificado y procedimiento para su preparacion.

Country Status (12)

Country Link
US (1) US6239261B1 (es)
EP (1) EP0383234B1 (es)
JP (1) JP2930243B2 (es)
KR (1) KR0149999B1 (es)
AT (1) ATE114669T1 (es)
AU (1) AU638969B2 (es)
CA (1) CA2009946C (es)
DE (2) DE3904354A1 (es)
DK (1) DK0383234T3 (es)
ES (1) ES2066020T3 (es)
IE (1) IE900511L (es)
PT (1) PT93128B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
FR2644064B1 (fr) * 1989-02-17 1994-05-27 Aquitaine Dev Transf Sanguine Procede de fabrication du facteur antihemophilique fviiic ayant une tres haute purete et facteur antihemophilique fviiic ainsi obtenu, ainsi que composition pharmaceutique le contenant
DE4435392B4 (de) * 1994-10-04 2008-02-07 Immuno Ag Verfahren zur Trennung von vWF in hochmolekularen vWF und niedermolekularen vWF
DE4435485C1 (de) * 1994-10-04 1996-03-21 Immuno Ag Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor
AT405403B (de) 1997-02-27 1999-08-25 Immuno Ag Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie
AT406867B (de) 1997-02-27 2000-10-25 Immuno Ag Verfahren zur gewinnung von hochreinem vwf oder faktor viii/vwf-komplex
US6605222B1 (en) * 1998-05-20 2003-08-12 Baxter Aktiengesellschaft Method for producing a factor VIII/von Willebrand factor complex
EP1820516B1 (en) 1999-02-22 2013-07-24 University of Connecticut Novel albumin-free factor VIII formulations
DE10022092A1 (de) * 2000-05-08 2001-11-15 Aventis Behring Gmbh Stabilisiertes Protein-Präparat und Verfahren zu seiner Herstellung
US7365173B2 (en) * 2002-02-04 2008-04-29 American National Red Cross Method for the production of pure virally inactivated butyrylcholinesterase
DE10246125A1 (de) * 2002-10-01 2004-04-15 Aventis Behring Gmbh Konzentrat eines Faktor VIII:C-haltigen von-Willebrand-Faktors und das dazu gehörige Verfahren
DE102004009400A1 (de) * 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
JP2007526329A (ja) * 2004-03-04 2007-09-13 ワイス 賦形剤の結晶化を改善するための凍結乾燥法
FR2874216B1 (fr) 2004-08-16 2006-11-03 Lab Francais Du Fractionnement Procede de preparation d'un concentre de facteur von willebrand (fvw) par voie chromatographique et concentre de fvw susceptible d'etre ainsi obtenu
JP2008512098A (ja) 2004-09-07 2008-04-24 アーケミックス コーポレイション フォン・ビルブラント因子に対するアプタマー、および血栓性疾患の処置剤としてのその使用
US7566701B2 (en) * 2004-09-07 2009-07-28 Archemix Corp. Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
AU2005282380A1 (en) * 2004-09-07 2006-03-16 Archemix Corp. Aptamer medicinal chemistry
WO2008150495A2 (en) * 2007-06-01 2008-12-11 Archemix Corp. Vwf aptamer formulations and methods for use
EP2385825B1 (en) 2008-11-07 2018-10-10 University of Connecticut Factor viii formulations
JP6583766B2 (ja) * 2015-02-02 2019-10-02 学校法人北里研究所 タンパク質分離方法、タンパク質分析方法、及びタンパク質分離キット
KR101841587B1 (ko) 2016-01-12 2018-05-14 주식회사 녹십자홀딩스 피브리노겐의 정제방법
CN105622747A (zh) * 2016-02-04 2016-06-01 江西博雅生物制药股份有限公司 一种vWF活性保护液
CN105541997A (zh) * 2016-02-04 2016-05-04 江西博雅生物制药股份有限公司 一种高纯度和高活性血管性血友病因子的制备工艺
CN105622746A (zh) * 2016-02-04 2016-06-01 江西博雅生物制药股份有限公司 一种从冷沉淀提取凝血因子ⅷ的废料中提取人血管性血友病因子的制备工艺

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4027013A (en) * 1976-01-22 1977-05-31 William L. Wilson Clottable fibrinogen free factor VIII and albumin product and process
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
US4278594A (en) 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
US4210580A (en) 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma
GB2079292A (en) 1980-07-05 1982-01-20 Speywood Lab Ltd Blood Clotting Factor Production
US4361509A (en) 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
DE3237512A1 (de) * 1982-10-09 1984-04-12 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipitat
GB8403473D0 (en) 1984-02-09 1984-03-14 Special Trustees For St Thomas Purification of factor viii
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
DE3707213A1 (de) * 1987-03-06 1988-09-15 Behringwerke Ag Verfahren zur herstellung von faktor viii:c-mangelplasma und ein so erhaltenes mangelplasma
US4774323A (en) * 1987-06-29 1988-09-27 Rorer Pharmaceutical Corporation Purification of von Willebrand Factor solutions using gel permeation chromatography
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.

Also Published As

Publication number Publication date
KR0149999B1 (ko) 1998-08-17
CA2009946C (en) 2000-04-11
AU638969B2 (en) 1993-07-15
ATE114669T1 (de) 1994-12-15
EP0383234A2 (de) 1990-08-22
CA2009946A1 (en) 1990-08-14
JPH02264799A (ja) 1990-10-29
EP0383234B1 (de) 1994-11-30
US6239261B1 (en) 2001-05-29
PT93128B (pt) 1995-12-29
DE3904354A1 (de) 1990-08-16
JP2930243B2 (ja) 1999-08-03
DE59007785D1 (de) 1995-01-12
KR900012615A (ko) 1990-09-01
DK0383234T3 (da) 1995-05-01
PT93128A (pt) 1990-08-31
AU4933990A (en) 1990-08-30
IE900511L (en) 1990-08-14
EP0383234A3 (de) 1991-08-07

Similar Documents

Publication Publication Date Title
EP0307510A3 (en) Process for combating fungicides
ES2182837T3 (es) Piran-2-onas y 5,6-dihidropiran-2-onas utiles en el tratamiento del sida y de otros retrovirus.
GT198400014A (es) Mejoras en o relativas a fenetanolaminas.
GB1079563A (en) Machines or harvesting tall crops
PT93128A (pt) Processo para a preparacao de um concentrado de factor de von willebrand purificado e pasteurizado
NO922639L (no) 8-vinyl- og 8-etinyl-kinolonkarboksylsyrer
ES2088009T3 (es) Agentes de bloqueo neuromuscular.
ES2103733T3 (es) Procedimiento para combatir el piojo de los peces.
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
GB1059930A (en) Containers formed of polyamides
IT8221506A0 (it) Soluzioni concentrate di coloranti 1,4-dialchil-arilammino antrachinoni per la colorazione diprodotti petroliferi.
EP0134441A3 (en) Sewing thread lubricants
ES2055268T3 (es) Combinaciones de productos activos fungicidas.
ES2134276T3 (es) Procedimiento para la preparacion de derivados isopropilidenicos de sacaridos.
GB1033240A (en) Tantalum base alloys
ITMI911644A1 (it) Eparine acilate come inibitori della replicazione di retrovirus
AT280572B (de) Vorrichtung zur schnittgerechten Aufgabe von langem Schnittgut, wie Rundholz od.dgl. auf eine dieses einer Säge zuführende Vorschubbahn
IT8321838A0 (it) Mono-, di- e trietilenglicol-alchil/aril-(3-iodi o-2-propinil)-eteri, procedimento per la loro produzione e loro impiego come agenti antimicrobici.
ES2066740B1 (es) Procedimiento de tratamiento de aguas residuales en un puesto de depuracion con el fin de eliminar las molestias olfativas.
FR1426277A (fr) Matrice de façonnage tel que poinçonnage, notamment pour l'industrie de la chaussure
ITRM920404A1 (it) Abito da lavoro modulare e componibile per pastori e ortolani.
ES2108350T3 (es) Procedimiento para la preparacion de 5-arilhidantoinas.
FR1514834A (fr) Machine pour le tri d'articles plats, tels que les lettres, les cartes-postales, etc.
TH8701000732EX (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH8702000380EX (th) สิทธิบัตรยังไม่ประกาศโฆษณา

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 383234

Country of ref document: ES